BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Pang YN, Zhang Y, Zhang ZR. Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting. World J Gastroenterol 2002; 8(5): 913-917 [PMID: 12378641 DOI: 10.3748/wjg.v8.i5.913]
URL: https://www.wjgnet.com/1007-9327/full/v8/i5/913.htm
Number Citing Articles
1
Robert C. Waters, Günther Hochhaus. Characterization of a dextran-budesonide prodrug for inhalation therapyEuropean Journal of Pharmaceutical Sciences 2019; 129: 58 doi: 10.1016/j.ejps.2018.11.038
2
Charles R. Nuttelman, Margaret C. Tripodi, Kristi S. Anseth. Dexamethasone‐functionalized gels induce osteogenic differentiation of encapsulated hMSCsJournal of Biomedical Materials Research Part A 2006; (1): 183 doi: 10.1002/jbm.a.30537
3
Divya Dheer, Divya Arora, Sundeep Jaglan, Ravindra K. Rawal, Ravi Shankar. Polysaccharides based nanomaterials for targeted anti-cancer drug deliveryJournal of Drug Targeting 2017; 25(1): 1 doi: 10.3109/1061186X.2016.1172589
4
A. J. Hao, Y. J. Deng, T. F. Li, X. B. Suo, Y. H. Cao, Y. L. Hao, Y. Zhang. Degradation Kinetics of Fluorouracil-Acetic-Acid-Dextran Conjugate in Aqueous SolutionDrug Development and Industrial Pharmacy 2006; 32(6): 757 doi: 10.1080/03639040600683436
5
Liang Ma, Tzu-Wen Liu, Matthew A. Wallig, Iwona T. Dobrucki, Lawrence W. Dobrucki, Erik R. Nelson, Kelly S. Swanson, Andrew M. Smith. Efficient Targeting of Adipose Tissue Macrophages in Obesity with Polysaccharide NanocarriersACS Nano 2016; 10(7): 6952 doi: 10.1021/acsnano.6b02878
6
Cody P. Coyne, Lakshmi Narayanan. Carnosic Acid, Tangeretin, and Ginkgolide-B Anti-neoplastic Cytotoxicity in Dual Combination with Dexamethasone-[anti-EGFR] in Pulmonary Adenocarcinoma (A549)Anti-Cancer Agents in Medicinal Chemistry 2019; 19(6): 802 doi: 10.2174/1871520619666181204100226
7
Adrian Hobson. The Medicinal Chemistry of Glucocorticoid Receptor ModulatorsSpringerBriefs in Molecular Science 2023; : 37 doi: 10.1007/978-3-031-28732-9_4
8
Masato SAKURAI, Yuichi OZEKI, Masaki ANDO, Hirokazu OKAMOTO, Kazumi DANJO. Preparation and Release Profile of Colon-Targeting Drug Delivered as Novel One-Step Dry-Coated Tablets (OSDrC<sup>®</sup>)YAKUGAKU ZASSHI 2007; 127(12): 2057 doi: 10.1248/yakushi.127.2057
9
Masato SAKURAI, Yuichi OZEKI, Masaki ANDO, Hirokazu OKAMOTO, Kazumi DANJO. Drug Delivery to the Colon Using a Novel One-Step Dry-Coated Tablets (OSDrC)YAKUGAKU ZASSHI 2008; 128(6): 951 doi: 10.1248/yakushi.128.951
10
Magharla Dasaratha Dhanaraju, Sheela Elizabeth, Thirumurugan Gunasekaran. Triamcinolone-loaded glutaraldehyde cross-linked chitosan microspheres: Prolonged release approach for the treatment of rheumatoid arthritisDrug Delivery 2011; 18(3): 198 doi: 10.3109/10717544.2010.528069
11
M. Nangrejo, Z. Ahmad, E. Stride, M. Edirisinghe, P. Colombo. Preparation of Polymeric and Ceramic Porous Capsules by a Novel Electrohydrodynamic ProcessPharmaceutical Development and Technology 2008; 13(5): 425 doi: 10.1080/10837450802247929
12
Barbara Tessier, Nicolas Tsapis, Elias Fattal, Laurence Moine. Emerging nanoparticle platforms to improve the administration of glucocorticoidsJournal of Controlled Release 2023; 358: 273 doi: 10.1016/j.jconrel.2023.04.039
13
Jaleh Varshosaz, Jaber Emami, Fatemeh Ahmadi, Naser Tavakoli, Mohsen Minaiyan, Afshin Fassihi, Parvin Mahzouni, Farid Dorkoosh. Preparation of budesonide–dextran conjugates using glutarate spacer as a colon-targeted drug delivery system:in vitro/in vivoevaluation in induced ulcerative colitisJournal of Drug Targeting 2011; 19(2): 140 doi: 10.3109/10611861003801826
14
Mirela Nadler Milabuer, Yossi Kam, Abraham Rubinstein. Oral Controlled Release Formulation Design and Drug Delivery2010; : 225 doi: 10.1002/9780470640487.ch14
15
Brian A. Yeagy, Almudena Prudencio, Robert C. Schmeltzer, Kathryn E. Uhrich, Thomas J. Cook. Characterization andin vitrodegradation of salicylate-derived poly(anhydride-ester microspheres)Journal of Microencapsulation 2006; 23(6): 643 doi: 10.1080/02652040600776481
16
Tamara Minko. Drug targeting to the colon with lectins and neoglycoconjugatesAdvanced Drug Delivery Reviews 2004; 56(4): 491 doi: 10.1016/j.addr.2003.10.017
17
M. A. Hussain, K. Abbas, I. Jantan, S. N. A. Bukhari. Polysaccharide-based materials in macromolecular prodrug design and developmentInternational Materials Reviews 2017; 62(2): 78 doi: 10.1080/09506608.2016.1209617
18
R. PAWAR, W. JADHAV, S. BHUSARE, R. BORADE, S. FARBER, D. ITZKOWITZ, A. DOMB. Natural-Based Polymers for Biomedical Applications2008; : 3 doi: 10.1533/9781845694814.1.3
19
Jaleh Varshosaz. Dextran conjugates in drug deliveryExpert Opinion on Drug Delivery 2012; 9(5): 509 doi: 10.1517/17425247.2012.673580
20
Catherine C. Applegate, Hongping Deng, Brittany L. Kleszynski, Tzu-Wen L. Cross, Christian J. Konopka, L. Wawrzyniec Dobrucki, Erik R. Nelson, Matthew A. Wallig, Andrew M. Smith, Kelly S. Swanson. Impact of administration route on nanocarrier biodistribution in a murine colitis modelJournal of Experimental Nanoscience 2022; 17(1): 599 doi: 10.1080/17458080.2022.2134563